Timothy Miller receives international innovation prize

Timothy Miller, MD, PhD, the David Clayson Professor of Neurology at Washington University School of Medicine in St. Louis, and a group of his colleagues have received the inaugural Healey Center International Prize for innovation in amyotrophic lateral sclerosis (ALS) research from the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital. […]

Antisense Drugs for Huntington’s, ALS and Prion Diseases Could Meet the Dire Need for Brain Treatments

Among the human body’s many maladies, few have stumped medical researchers like those that decimate the brain. After decades of effort, effectively treating—let alone curing—neurodegenerative disorders such as Huntington’s and Alzheimer’s disease has been a source of frustration for many, as old theories are questioned and clinical trials fail. Basic scientists have achieved some progress. […]

Experimental treatment could be ‘game-changing’ for genetic ALS, experts say

An experimental treatment for the rapidly progressive disease ALS, or amyotrophic lateral sclerosis, has been called potentially “game-changing.” The treatment, called tofersen, was found to slow the decline of muscular function associated with a genetic form of ALS in a study to be presented next week at the annual meeting of the American Academy of […]

New ALS therapy in clinical trials

Drug extends survival, reverses some neuromuscular damage in animals From the WashU School of Medicine News… About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The invariably fatal disease kills the nerve cells that control walking, eating and breathing. Few people survive more than […]

Miller receives Essey award from neurological society

Recognized for advancing research into ALS From the WashU Newsroom… Timothy Miller, MD, PhD, the Clayson Professor of Neurology at Washington University School of Medicine in St. Louis, has received the 2018 Sheila Essey Award from the American Academy of Neurology. The award includes $50,000 to support his work on amyotrophic lateral sclerosis (ALS), commonly […]

Pursuing a precision paradigm

Why move from current standards of patient care to a more personalized approach to treatment? Experts at the School of Medicine describe today’s medical landscape as they plan for the care — and cures — of the future. From the WashU Newsroom… Of the top-grossing domestic movies of 2017 to date, three of the Top 5 […]